These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 8250739
1. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis. de Graaf J, Hendriks JC, Swinkels DW, Demacker PN, Stalenhoef AF. Artery; 1993; 20(4):201-30. PubMed ID: 8250739 [Abstract] [Full Text] [Related]
2. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN. Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544 [Abstract] [Full Text] [Related]
3. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. Brown BE, Rashid I, van Reyk DM, Davies MJ. FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204 [Abstract] [Full Text] [Related]
4. Differences in metabolism of three low density lipoprotein subfractions in Hep G2 cells. Swinkels DW, Hendriks JC, Demacker PN, Stalenhoef AF. Biochim Biophys Acta; 1990 Dec 04; 1047(3):212-22. PubMed ID: 2174703 [Abstract] [Full Text] [Related]
5. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, Nakamura H. Artery; 1993 Dec 04; 20(1):1-18. PubMed ID: 8447724 [Abstract] [Full Text] [Related]
6. Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls. de Graaf J, Swinkels DW, Demacker PN, de Haan AF, Stalenhoef AF. J Clin Endocrinol Metab; 1993 Jan 04; 76(1):197-202. PubMed ID: 8421088 [Abstract] [Full Text] [Related]
7. Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties. Packard CJ, Shepherd J, Joerns S, Gotto AM, Taunton OD. Biochim Biophys Acta; 1979 Feb 26; 572(2):269-82. PubMed ID: 218633 [Abstract] [Full Text] [Related]
8. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Arterioscler Thromb; 1991 Feb 26; 11(2):298-306. PubMed ID: 1998647 [Abstract] [Full Text] [Related]
9. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. Llorente-Cortés V, Royo T, Otero-Viñas M, Berrozpe M, Badimon L. Cardiovasc Res; 2007 Jun 01; 74(3):526-36. PubMed ID: 17376415 [Abstract] [Full Text] [Related]
13. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Geiss HC, Otto C, Parhofer KG. Metabolism; 2006 May 01; 55(5):599-604. PubMed ID: 16631435 [Abstract] [Full Text] [Related]
16. Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study. Leonhardt W, Pfützner A, Müller J, Pietzsch J, Forst T, Karagiannis E, Lübben G, Hanefeld M. Atherosclerosis; 2008 Nov 01; 201(1):155-62. PubMed ID: 18374336 [Abstract] [Full Text] [Related]